Winton Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-74,936
Closed -$1.86M – 1150
2026
Q2
$1.86M Buy
+74,936
New +$1.75M 0.06% 307
2020
Q3
– Sell
-25,773
Closed -$757K – 1471
2020
Q2
$757K Buy
25,773
+7,715
+43% +$223K 0.02% 1077
2020
Q1
$486K Buy
+18,058
New +$539K 0.01% 1040
2018
Q4
– Sell
-161,191
Closed -$11M – 865
2018
Q3
$11M Buy
+161,191
New +$10.4M 0.23% 177
2017
Q1
– Sell
-31,922
Closed -$1.18M – 431
2016
Q4
$1.18M Buy
+31,922
New +$1.14M 0.04% 310

Other funds holding AVNS

Winton Group's AVNS Position: Q3 2026 in Review

Winton Group sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 74,936 shares — an estimated $1.86M sold.

Winton Group first reported a position in AVNS in Q4 2016 and held it in 5 quarters. The position peaked at $11M in Q3 2018. 3 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

  • Winton Group reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
  • Winton Group sold 74,936 Avanos Medical shares in Q3 2026, an estimated $1.86M.
  • Winton Group first reported a position in Avanos Medical in Q4 2016 and held it in 5 quarters.
  • Winton Group's Avanos Medical position peaked at $11M in Q3 2018.
  • 3 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on Winton Group's 13F filing for Q3 2026, filed 12 Nov 2026.